E-LIB Suche - Ergebnisse für: Poza, Maria

1

Corrigendum: Personalized monitoring of circulating tumor D..:

Jiménez-Ubieto, Ana ; Martín-Muñoz, Alejandro ; Poza, María...
Frontiers in Immunology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

New therapies for relapsed or refractory aggressive B‐cell ..:

Bastos‐Oreiro, Mariana ; Abrisqueta, Pau ; Gutierrez, Antonio...
HemaSphere. 8 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

3

Real-life disease monitoring in follicular lymphoma patient..:

Jiménez-Ubieto, Ana ; Poza, María ; Martin-Muñoz, Alejandro...
Leukemia. , 2023

Link: https://doi.org/10.1038/..

4

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Co..:

Figaredo, Gloria ; Martín-Muñoz, Alejandro ; Barrio, Santiago...
Cancers. 15 (2023) 16 - p. 4022 , 2023

Link: https://doi.org/10.3390/..

5

Impact of IPSS-M implementation in real-life clinical pract..:

Zamanillo, Irene ; Poza, Maria ; Ayala, Rosa...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Corrigendum: Personalized monitoring of circulating tumor D..:

Jiménez-Ubieto, Ana ; Martín-Muñoz, Alejandro ; Poza, María...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

P1100: PET INTERIM RESULTS COULD PROMPTLY SELECT FOLLICULAR..:

Poza, Maria ; López-Pereira, Patricia ; Figaredo García-Mina, Gloria...
HemaSphere. 7 (2023) S3 - p. e8923396 , 2023

Link: https://doi.org/10.1097/..

8

Personalized monitoring of circulating tumor DNA with a spe..:

Jiménez-Ubieto, Ana ; Martín-Muñoz, Alejandro ; Poza, María...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Ibrutinib effect in acquired von Willebrand syndrome second..:

Poza, María ; Íñiguez, Rodrigo ; Zamanillo, Irene...
Therapeutic Advances in Hematology. 12 (2021) - p. 204062072110393 , 2021

Link: https://doi.org/10.1177/..

10

P-226: Clinical outcomes of Multiple Myeloma patients after..:

Zamanillo, Irene ; De la Puerta, Rosalia ; gil, Rodrigo...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S164-S165 , 2021

Link: https://doi.org/10.1016/..

11

Making clinical decisions based on measurable residual dise..:

Martinez-Lopez, Joaquin ; Alonso, Rafael ; Wong, Sandy W....
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

P-148: Real-life analysis of the multiple myeloma patient's..:

López-Muñoz, Nieves ; García, Rodrigo Íñiguez ; Fernández, Rafael Alberto Alonso...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S116 , 2021

Link: https://doi.org/10.1016/..

13

Clonal hematopoiesis-defining mutations have no impact on t..:

Álvarez, Noemí ; Rodríguez-García, Alba ; Morales, María Luz...
Leukemia Research. 108 (2021) - p. 106613 , 2021

Link: https://doi.org/10.1016/..

14

IL-1R blockade is not effective in patients with hematologi..:

Villegas, Carolina ; Poza, María ; Talayero, Paloma...
Annals of Hematology. 99 (2020) 12 - p. 2953-2956 , 2020

Link: https://doi.org/10.1007/..

15

Clinical course and risk factors for mortality from COVID‐1..:

Sanchez‐Pina, José María ; Rodríguez Rodriguez, Mario ; Castro Quismondo, Nerea...
European Journal of Haematology. 105 (2020) 5 - p. 597-607 , 2020

Link: https://doi.org/10.1111/..